The approval was based on data from 5 randomized, double-blind, placebo-controlled trials that included 317 patients with supraventricular tachycardia. Landiolol is a selective beta-1 adrenergic ...

Shares of Milestone Pharmaceuticals Inc. gained 25.4% in premarket trading on Monday after the company said its experimental treatment for paroxysmal supraventricular tachycardia met the primary ...

First and only contact force pulsed field ablation (PFA) system engineered to revolutionize care for the hundreds of thousands at risk of death from ventricular tachycardia (VT). FDA's TAP Pilot and ...

Please provide your email address to receive an email when new articles are posted on . A fast-acting nasal spray was safe and effective for patients self-treating for repeated episodes of paroxysmal ...

The Agency has specifically requested clarification about the time of data recorded for adverse events in the phase 3 trials. The Food and Drug Administration (FDA) has issued a Refusal to File (RTF) ...

For most adults, the heart beats 60 to 100 times per minute. When someone’s heart beats more than 100 times per minute, they have a condition called tachycardia. During certain specific experiences, ...

St. Jude Medical Begins Landmark Clinical Study to Evaluate Effectiveness of Ablation Procedures for Treatment of Ventricular Tachycardia FlexAbility ablation catheter will be used to assess benefits ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermedical ®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today it has received $3 million in grant funding (1R44HL169112) ...

A recent article published in BMJ discussed the prevalence, assessment, and practice pointers for the management of presentations of tachycardia among long coronavirus disease (long COVID). Long COVID ...

Catheter Precision, Inc. has formed a joint venture named Kardionav with Chelak iECG, Inc. to develop advanced technologies aimed at improving ablation procedures for ventricular tachycardia. Catheter ...